A thermostable mRNA vaccine against COVID-19

Zhang, Na-Na, Li, Xiao-Feng, Deng, Yong-Qiang, Zhao, Hui, Huang, Yi-Jiao, Yang, Guan, Huang, Wei-Jin, Gao, Peng +23 more·2020·Cell
DOI 10.1016/j.cell.2020.07.024

Cited by (670)

Items 401–500 of 670

  1. Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization—A community-based questionnaire study
    Pei‐Yun Chen, Pei-Ni Chuang, Chien‐Hsieh Chiang, Hao Chang, Chia‐Wen Lu, Kuo‐Chin Huang · 2022 · PLoS ONE
  2. IRES-Mediated Translation: Expanding the Toolkits of RNA Therapy
    Xiang Gao, Zhenfang Wu · 2025 · International Journal of Molecular Sciences
  3. Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution
    Xu, Xin, Cui, Lili, Zhang, Yong, Gu, Jingkai · 2026 · Acta Pharmaceutica Sinica B
  4. Navigating the Biomolecular Corona: Biological Interactions and Therapeutic Implications of RNA–Lipid Nanoparticles
    Anamika Saini, Shiyao Li, Zhaoran Wang, Magdalena Plebanski, Yi Ju · 2026 · ACS Nano
  5. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine
    Bagher A. Larijani, Najmeh Foroughi Heravani, Mina Abedi, Akram Tayanloo-Beik, Mostafa Rezaei–Tavirani, Hossein Adibi, Babak Arjmand · 2021 · Frontiers in Cell and Developmental Biology
  6. Formulation of Lipid-Free Polymeric Mesoscale Nanoparticles Encapsulating mRNA
    Rachel N. Skelton, Arantxa Roach, Lauren E. Prudhomme, Jing Yu Carolina Cen Feng, Pooja Gaikwad, Ryan Martin Williams · 2022 · Pharmaceutical Research
  7. Regulatory perspective for quality evaluation of lipid nanoparticle-based mRNA vaccines in China
    Jiaqi Lu, Wei Wei, Wu He · 2023 · Biologicals
  8. The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
    Craig P. Collins, Dan L. Longo, William J. Murphy · 2024 · Frontiers in Immunology
  9. Probing the interaction mechanisms of lipid nanoparticle-encapsulated mRNA with surfaces of diverse functional groups: Implication for mRNA transport
    Jingyi Wang, Jiawen Zhang, Sijia Li, Hui Qian, Dengfeng Liu, Isaias Prado, Sharon Wang, Akhilesh Bhambhani, Hongbo Zeng · 2024 · Chemical Engineering Science
  10. A synthetic cyclic peptide for promoting antigen presentation and immune activation
    Jiahui Zhang, Harrison Y. R. Madge, Asmaa Mahmoud et al. · 2025 · npj Vaccines
  11. mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
    Saeideh Khorshid Sokhangouy, Matine Behzadi, Shokuh Rezaei, Mahsa Farjami, Milad Haghshenas, Yahya Sefidbakht, Sina Mozaffari‐Jovin · 2025 · Biotechnology Journal
  12. PEG‐Free Monosialoganglioside Lipid Nanoparticles with Spleen‐Selective mRNA Delivery for Cancer Immunotherapy
    Ziqian Wang, Xingwu Liu, Jiahui Jin, Xiaoyi Liu, Cong Liu, Fengfei Xie, Xingyun Wang, Fangjie An, Bao Xiao, Hanchao Cheng et al. · 2025 · Advanced Functional Materials
  13. Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
    Wenjuan Li, Xingxing Li, Danhua Zhao · 2021 · Signal Transduction and Targeted Therapy
  14. Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
    Prashant Kumar, Michael Wang, Ozan S. Kumru, John M. Hickey, Julio C. Sanmiguel, Nerea Zabaleta, Luk H. Vandenberghe, Sangeeta B. Joshi, David B. Volkin · 2023 · Molecular Therapy — Methods & Clinical Development
  15. Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus
    Shuo Wang, Ziling Zhu, Jianmin Li · 2024 · Molecular Pharmaceutics
  16. Knowledge and awareness among physiotherapy students to combat COVID-19: A questionnaire based study
    Mandeep Kumar Jangra, Akanksha Saxena, Praharsh Anurag · 2021 · Clinical Epidemiology and Global Health
  17. The development of China’s vaccine industry in the past decade: the perspective from drug regulatory science
    Guan-Jie Wang, Mingli Shao · 2021 · Human Vaccines & Immunotherapeutics
  18. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
    Peixian Chen, Xiaoye Shi, Weixin He, Guowei Zhong, Yan Tang, Hailin Wang, Peidong Zhang · 2022 · Human Vaccines & Immunotherapeutics
  19. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2022 · PLoS Pathogens
  20. Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models
    Shahram Nazarian, Gholamreza Olad, Raziyeh Abdolhamidi, Mohammad Javad Motamedi, Rouhollah Kazemi, Emad Kordbacheh, Alireza Felagari, Hanieh Olad, Ali Ahmadi, Alireza Bahiraee et al. · 2022 · Molecular Immunology
  21. Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models
    Ricardo Choque-Guevara, Astrid Poma-Acevedo, Ricardo Montesinos, Dora Ríos-Matos, Kristel Gutiérrez-Manchay, Ángela Montalván-Ávalos, Stefany Quiñones-García, Maria De Grecia Cauti Mendoza, Andrés Agurto-Arteaga, Ingrid Ramirez-Ortiz et al. · 2022 · PLoS ONE
  22. A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques
    Paul E. Harris, Trevor Brasel, Christopher Massey et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases
    Jennifer Soto, Chase S. Linsley, Yang Song, Binru Chen, Jun Fang, Josephine Neyyan, Raul Davila, Brandon S. Lee, Benjamin M. Wu, Song Li · 2023 · Nanomaterials
  24. Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction
    Ankita Saha, Shweta Choudhary, Priyanshu Walia, Pravindra Kumar, Shailly Tomar · 2025 · Virology
  25. mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications
    Radhika Joshi, Swapnil Sharma, Devesh U. Kapoor, Bhupendra G. Prajapati, Kampanart Huanbutta, Pornsak Sriamornsak · 2026 · Molecular Pharmaceutics
  26. Coronavirus - A Crippling Affliction to Humans
    Rimple Kaul, Sunita Devi · 2022 · Recent Patents on Biotechnology
  27. Emerging trends of research on mRNA vaccines: A co-citation analysis
    Juan Chen, Ting Zhang, Yan Zhen Lu, Xiaoyi Yang, Zhaolian Ouyang · 2022 · Human Vaccines & Immunotherapeutics
  28. Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection
    Yanhao Zhang, Ji Wang, Hanlei Xing, Chao Liu, Wenhui Zha, Shuo Dong, Yuhao Jiang, Xinsong Li · 2023 · Journal of Materials Chemistry B
  29. Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial
    Suad Hannawi, Xiaohong Wu, Ralph Elvi Villalobos, Erlina Burhan, Ma. Dovie Lallaine Borra, Rakesh Kumar Gupta, Grace P. Aquitania, Blake Warren Ang, Gelza Mae A Zabat, Camilo C. Roa et al. · 2024 · Med
  30. Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses
    Zuxin Liang, Chunhui Li, Xiaohua Gong, Guoguo Ye, Yushan Jiang, Huiping Shi, Abid Hussain, Mengyuan Zhao, Mengjun Li, Yuxin Tian et al. · 2024 · PLoS Pathogens
  31. Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19
    JIAO JIAN TONG, Chenxi Zhu, Hanyu Lai, Chunchao Feng, Dapeng Zhou · 2021 · Vaccines
  32. An Engineered IgG–VHH Bispecific Antibody against SARS‐CoV‐2 and Its Variants
    Hang Chi, Lei Wang, Chanjuan Liu, Xiaohe Cheng, Hailiang Zheng, Lilang Lv, Yongcong Tan, Nana Zhang, Suo-Qun Zhao, Mei Wu et al. · 2022 · Small Methods
  33. mRNA—From COVID-19 Treatment to Cancer Immunotherapy
    W. Kŕause · 2023 · Biomedicines
  34. Nanoagent-based theranostic strategies against human coronaviruses
    Tao Feng, Chaofan Nie, Pan-Di Peng, Hui Lu, Tengjiao Wang, Peng Li, Wei Huang · 2022 · Nano Reseach
  35. Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination
    Xiaomei Zhang, Mei Zheng, Te Liang, Haijian Zhou, Hongye Wang, Jiahui Zhang, Jing Fei Ren, Huoying Peng, Siping Li, Haodong Bian et al. · 2022 · Theranostics
  36. Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein
    Duško Lainšček, Tina Fink, Vida Forstnerič et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  37. MHCI trafficking signal‐based mRNA vaccines strengthening immune protection against RNA viruses
    Yupei Zhang, Songhui Zhai, Shugang Qin, Yuting Chen, Kepan Chen, Zhiying Huang, Xing Lan, Yaoyao Luo, Guo-Hong Li, Hao Li et al. · 2024 · Bioengineering & Translational Medicine
  38. Innovative DNA tetrahedron inspired by ancient mortise-and-tenon technique offers new immunotherapy strategy for metastatic breast cancer
    Nan Zhang, Qian Lu, Chang Xu, Fangfang Duan, Yuxuan Ma, Li Zhou, Yuting Zhang, Yi Ma, Qiao Lin, Kai Lu · 2025 · Biomaterials
  39. Recent Developments of RNA Vaccines and Therapeutics: Reagents, Formulations, and Characterization
    Mhd Anas Tomeh, Rachel K. Smith, Allan Watkinson · 2025 · Molecular Pharmaceutics
  40. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database
    Hassan Hussein Musa, Taha Hussein Musa · 2022 · Human Vaccines & Immunotherapeutics
  41. Innovative translational platforms for rapid developing clinical vaccines against COVID‐19 and other infectious disease
    Ning Wang, Ting Wang · 2024 · Biotechnology Journal
  42. Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events
    Uday Pratap Singh Parmar, Pier Luigi Surico, Rohan Bir Singh, Mutali Musa, Anna Scarabosio, Giorgio Surico, Antonino Maniaci, Salvatore Lavalle, Fabiana D’Esposito, Antonio Longo et al. · 2024 · Journal of Personalized Medicine
  43. Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris
    Tongxin Zhao, Sheng Liu, Pengyan Wang, Yanfang Zhang, Xinrui Kang, X. Pan, Lin-Jie Li, Dedong Li, Ping Gao, Yaling An et al. · 2024 · PLoS Pathogens
  44. The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations
    Sarah Parsons, Van L. Tran · 2021 · The Journal of Pediatric Pharmacology and Therapeutics
  45. Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19
    Zehua Zhou, Xinyu Zhang, Qianqian Li, Lili Fu, Meiyu Wang, Shuo Liu, Jiajing Wu, Jianhui Nie, Li Zhang, Chenyan Zhao et al. · 2021 · Vaccine
  46. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
    Mai Abdel Haleem Abusalah, Moad Khalifa, Mohammad A. I. Al-Hatamleh, Mu’taman Jarrar, Rohimah Mohamud, Chan Yean Yean · 2022 · Journal of Personalized Medicine
  47. Multimodality imaging of nanoparticle‐based vaccines: Shedding light on immunology
    Muhsin H. Younis, Zhongmin Tang, Weibo Cai · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  48. Recent and advanced nano-technological strategies for COVID-19 vaccine development
    Chinekwu Sherridan Nwagwu, Chinenye Nnenna Ugwu, John Dike Ogbonna, Adaeze Linda Onugwu, Chinazom Precious Agbo, Adaeze Chidiebere Echezona, Ezinwanne Nneoma Ezeibe, Samuel Wisdom Uzondu, Franklin Chimaobi Kenechukwu, Paul Achile Akpa et al. · 2022 · Methods in microbiology
  49. Design and Immunoinformatic Assessment of Candidate Multivariant mRNA Vaccine Construct against Immune Escape Variants of SARS-CoV-2
    Mushtaq Hussain, Anusha Amanullah, Ayesha Aslam, Fozia Raza, Shabana Arzoo, Iffat Waqar Qureshi, Humera Waheed, Nusrat Jabeen, Sanya Shabbir, Muneeba Ahsan Sayeed et al. · 2022 · Polymers
  50. Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019
    Halle Lutz, Kristen D. Popowski, Phuong‐Uyen Dinh, Ke Cheng · 2020 · Advanced NanoBiomed Research
  51. Potential Application of Bionanoparticles to Treat Severe Acute Respiratory Syndrome Coronavirus-2 Infection
    Sujit Kumar Debnath, Rohit Srivastava · 2022 · Frontiers in Nanotechnology
  52. The Chimera of TPGS and Nanoscale Lipid Carriers as Lymphatic Drug Delivery Vehicles to Fight Metastatic Cancers
    Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Fars Kaed Alanazi · 2023 · Current Drug Delivery
  53. Dendritic cell-based biomimetic nanoparticles for foot-and-mouth disease induce robust cellular immunity
    Zhan Gao, Xiaoqing Liu, Yao Lei, Junjun Shao, Guanglei Zhang, Guangqing Zhou, Guangqing Zhou, Jin’en Wu, Huichen Guo, Huiyun Chang et al. · 2024 · Antiviral Research
  54. Cationic lipid nanoparticles for nucleic acid delivery: microfluidics versus thin film hydration
    Hyeseon Park, Jae‐Seong Lee, Jeon-Woong Kang, Ji-Young Min, Jeongmin Lee, Jiwoo Hong, Gayong Shim · 2025 · Journal of Pharmaceutical Investigation
  55. Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies
    Irene Santamaria-Castro, Rocío Leiva-Rebollo, Sonia Marín‐Wong, Jose M. Jiménez-Guardeño, Ana Maria Ortega‐Prieto · 2025 · Microbiology and Molecular Biology Reviews
  56. Gold Nanoparticle–mRNA Conjugates Encapsulated in Lipid Nanoparticles for Coordinated Codelivery of Multiple mRNAs
    Dajeong Hwang, Sin A Park, Jae Hoon Kim, Seung-Yeul Lee, Jaebeom Lee, Han Sang Kim, Kyung‐A Kim, Seung‐Hoon Lee, Tae Jeong Oh, Jae‐Wook Lee et al. · 2025 · ACS Omega
  57. Recent advances in freeze-drying technologies for mRNA vaccines against infectious diseases
    Jinghu Lou, Zhihai Wu, Yi Cheng, Meng Li, Nan Liu, Zengming Wang, Xiang Gao, Aiping Zheng, Hui Zhang · 2025 · International Journal of Pharmaceutics
  58. An Outline of Contributing Vaccine Technologies for SARS CoV2 Advancing in Clinical and Preclinical Phase-Trials
    Sheikh Saba Naz, Iqra Munir · 2022 · Recent Patents on Biotechnology
  59. Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review
    Smita Pawar, Prashant Pingale, Atul Garkal, Riyaz Ali M. Osmani, Kavita Rai Gajbhiye, Madhur Kulkarni, Krutika Pardeshi, Tejal A Mehta, Amarjitsing Rajput · 2024 · International Journal of Biological Macromolecules
  60. A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants
    Tian-Jiao Hao, Yu-Lei Li, Peipei Liu, Xi Wang, Ke Xu, Wen-Wen Lei, Ying Li, Rong Zhang, Xiaoyan Li, Xin Zhao et al. · 2024 · PLoS Pathogens
  61. Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates
    Alexandra Detrille, Steve Huvelle, Marit J. van Gils, Tatiana Geara, Quentin Pascal, Jonne L. Snitselaar, Laëtitia Bossevot, Mariangela Cavarelli, Nathalie Dereuddre‐Bosquet, Francis Relouzat et al. · 2025 · Nature Communications
  62. Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection
    Hao Sun, Xiaojuan Su, Lingyi Huang, Dezhi Mu, Yi Qu · 2021 · Biomolecules
  63. Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo
    Treniece L. Terry, Brittany E. Givens, Andrea Adamcakova‐Dodd, Peter S. Thorne, V.G.J. Rodgers, Aliasger K. Salem · 2021 · AAPS PharmSciTech
  64. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
    Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha · 2021 · Life Sciences
  65. A Murine CD8+ T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
    Jihyun Yang, Eun‐Jin Kim, Jong‐Soo Lee, Haryoung Poo · 2021 · Vaccines
  66. Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization
    Ji Wang, Yanhao Zhang, Chao Liu, Wenhui Zha, Shuo Dong, Yang Wang, Yuhao Jiang, Hanlei Xing, Xinsong Li · 2023 · Molecular Pharmaceutics
  67. SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations
    Xiaohan Zhang, Mansheng Li, Nana Zhang, Yunhui Li, Fei Teng, Yongzhe Li, Xiaomei Zhang, Xingming Xu, Haolong Li, Yunping Zhu et al. · 2024 · Advanced Science
  68. mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
    Hareth A. Al-Wassiti, Stewart A. Fabb, Samantha L. Grimley, Ruby Kochappan, Joan K. Ho, Chinn Yi Wong, Chee Wah Tan, Thomas J. Payne, Asuka Takanashi, Chee Leng Lee et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  69. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?
    Sheyda Ranjbar, Yousef Fatahi, Fatemeh Atyabi · 2021 · Journal of Drug Delivery Science and Technology
  70. Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines
    Sukrit Srivastava, S.D. Chatziefthimiou, Michael Kolbe · 2021 · Methods in molecular biology
  71. An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
    Jun Zuo, Jiayu Wu, Zhen Zhang · 2025 · Vaccines
  72. A Single-Chain Mpox mRNA Vaccine Elicits Protective Immune Response in Mice
    Qian Xu, Rongrong Zhang, Mei Wu et al. · 2025 · Vaccines
  73. Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad‐Neutralizing Antibody Response against SARS‐CoV‐2 Omicron Subvariants
    Guangxu Zhang, Qian Wang, Kai Ji et al. · 2025 · MedComm
  74. A new type of lipid nanoparticles with sphingomyelin-induced active lipid raft structures for improved mRNA cellular uptake
    Dandan Ling, Na Li, Xiaobin Pan, Weixiang Gao, Li P. Hao, Qi Tian, Jing Li, Qin Cheng, Liang Tang, Jerry Zhang et al. · 2026 · Journal of Controlled Release
  75. Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy
    Li Li, Xiuli Yan, H Wang, Hangyu Zhou, Yu-Yan Li, Wenlong Ma, Li J, Rong-Rong Zhang, Lu Lv, Xing‐Yao Huang et al. · 2026 · Cell
  76. S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
    Yong‐Sik Bong, David Alan Brown, Ezra Chung et al. · 2025 · Frontiers in Immunology
  77. COVID-19 vaccines: challenges and solutions
    Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Mandana Afsharian, Soheil Ebrahimpour · 2022 · Minerva Respiratory Medicine
  78. A Comparative Study of Pre-trained Gene Embeddings for COVID-19 mRNA Vaccine Degradation Prediction
    U. Vamsi Krishna, B. Premjith, K. P. Soman · 2022 · Advances in intelligent systems and computing
  79. A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine
    Dong Liu, Chaoqiang An, Yu Bai, Kelei Li, Jianyang Liu, Qian Wang, Qian He, Ziyang Song, Jialu Zhang, Lifang Song et al. · 2022 · Viruses
  80. Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice
    Zhuo-xin Li, Sheng Feng, He Zhang et al. · 2022 · Archives of Virology
  81. Lipid nanoparticle‐mediated delivery of IL‐21‐encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence
    Zhongliang Shen, Shenyan Zhang, Qirong Jiang, Nannan Liu, Fahong Li, Zixiang Gao, Shaokun Pan, Weiju Hao, Qiang Deng, Jing Liu et al. · 2023 · Journal of Medical Virology
  82. Synthesis of cell penetrating peptide sterol coupler and its liposome study on S-mRNA
    Yuan Li, Wenlin Ma, Wen‐Yu Su, Zhihong Yan, Lin Jia, Jie Deng, Ali Zhu, Yanbo Xie, Xinyi Li, Wanhui Shao et al. · 2023 · European Journal of Medicinal Chemistry
  83. Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants
    Yan Ling Wu, Jian R. Shi, Xiaoxue He, Jia Lu, Xiao Gao, Xuerui Zhu, Xinlan Chen, Man Zhang, Lijuan Fang, Jing Zhang et al. · 2023 · Journal of Virology
  84. Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
    Hui John Zhao, Nana Zhang, Suad Hannawi et al. · 2024 · Cell Discovery
  85. Lipid-based nanoparticles and their recent advances
    Onteru Sujeevan · 2024 · GSC Advanced Research and Reviews
  86. LNP-mRNA delivers TNF-α antibody to deep cartilage and protects against osteoarthritis
    Baixing Li, Lei Cui, Keyu Kong, Yichuan Pang, Yan Chen, Shuning Zhang, Fangfang Wang, Tangjun Zhou, Yunfeng Hua, Cao Mi et al. · 2024 · Chemical Engineering Journal
  87. Navigating the Quagmire: Comparison and Interpretation of COVID-19 Vaccine Phase 1/2 Clinical Trials
    Luca Tudor Giurgea, Matthew James Memoli · 2020 · Vaccines
  88. Future of nanotechnology in tissue engineering
    Vineeth M. Vijayan, Gerardo Hernandez‐Moreno, Vinoy Thomas · 2022 · Elsevier eBooks
  89. Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
    Xiaofeng Li, Nana Zhang, Yuhua Li · 2022 · Human Vaccines & Immunotherapeutics
  90. An Expert System Dataset for Checking the Potential for Administering a Covid-19 Vaccine in Indonesia: Forward-Chaining Inference Machine Approach
    Rosyid Ridlo Al Hakim, Glagah E. Setyowisnu, Agung Pangestu · 2022 · Journal of Global Engineering Research and Science
  91. Distribution of intra‐host variations and mutations in the genomes of SARS‐CoV‐2 and their implications on detection and therapeutics
    Dongyan Xiong, Xiaoxu Zhang, Junping Yu · 2022 · MedComm
  92. Advances in mRNA vaccines for viral diseases
    Yukai Huang, Xuerui Zhu, Xiao Guo, Yuancheng Zhou, Dongying Liu, Jingrui Mao, Yongai Xiong, Youcai Deng, Xinghong Gao · 2023 · Journal of Medical Virology
  93. Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine
    Zhou, Chao, Sun, Mengxu, Huang, Xingyao, Liu, Pu, Ouyang, Zhangyi, Wu, Mei, Yuan, Lin, Chen, Jingjing, Shu, Wenjie, Cao, Tianshu et al. · 2025 · hLife
  94. A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform
    Ying-Ying Jiang, M. Sanyal, Noor A. Hussein, Ani Baghdasaryan, Mengzhen Zhang, Fei-Fei Wang, Fuqiang Ren, Jiachen Li, Guan-Zhou Zhu, Yifan Meng et al. · 2025 · Science Advances
  95. Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infections
    Cuifeng Li, Yuxin Li, Bini Zhou, Tong Li, Xiaohui Wei, Kun Chen, Wenlong Chen, Ziwei Shi, Xiaobin Dai, Jiachen Zhang et al. · 2025 · Nature Biomedical Engineering
  96. Engineered strategies for enhancing mRNA vaccine stability in delivery and storage
    Elif Naz Cerav, Zhiying Yao, Bingbing Sun · 2026 · Nanoscale
  97. Exploring the impact of lipid nanoparticles on protein stability and cellular proteostasis
    Zifan Gao, Biao Jing, Yuhui Wang, Wang Wan, Xuepeng Dong, Yu Liu · 2024 · Journal of Colloid and Interface Science
  98. Chemical cross‐linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual‐antigen subunit vaccine
    Long Chen, Chao Shang, Zihao Wang et al. · 2025 · MedComm
  99. Pan-membrane pyroptosis of liver induced by gasdermin-encoding mRNAs
    Yi-Jiao Huang, Li Lin, Guan Yang, Wenlong Ma, Qin Wang, Xiuli Yan, Qing Ye, Xing‐Yao Huang, Kai Li, Lu Lv et al. · 2025 · National Science Review
  100. COVID-19 mRNA Vaccine Degradation Prediction By Using Deep Learning Algorithms
    Ooi Nian Chze, Azian Azamimi Abdullah · 2022 · International Conference on Innovation and Intelligence for Informatics, Computing, and Technologies (3ICT)